Riccardo Perfetti is Chief Medical Officer of Applied Therapeutics Inc.. Currently has a direct ownership of 986,853 shares of APLT, which is worth approximately $9.09 Million. The most recent transaction as insider was on Aug 22, 2024, when has been sold 22,681 shares (Common Stock) at a price of $5.83 per share, resulting in proceeds of $132,230. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 987K
2.25% 3M change
42.21% 12M change
Total Value Held $9.09 Million

Riccardo Perfetti Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 22 2024
SELL
Open market or private sale
$132,230 $5.83 p/Share
22,681 Reduced 2.25%
986,853 Common Stock
Jun 06 2024
SELL
Open market or private sale
$95,052 $4.32 p/Share
22,003 Reduced 2.13%
1,009,534 Common Stock
Mar 14 2024
SELL
Open market or private sale
$597,233 $5.39 p/Share
110,804 Reduced 9.7%
1,031,537 Common Stock
Dec 21 2023
BUY
Grant, award, or other acquisition
-
450,000 Added 28.26%
1,142,341 Common Stock
Nov 30 2023
SELL
Open market or private sale
$3,118 $1.97 p/Share
1,583 Reduced 0.23%
692,341 Common Stock
Sep 27 2023
SELL
Open market or private sale
$29,516 $2.7 p/Share
10,932 Reduced 1.55%
693,924 Common Stock
Jan 11 2023
SELL
Open market or private sale
$5,508 $0.91 p/Share
6,053 Reduced 3.76%
154,856 Common Stock
Jan 11 2023
BUY
Grant, award, or other acquisition
-
550,000 Added 43.83%
704,856 Common Stock
Mar 23 2022
BUY
Open market or private purchase
$59,100 $1.97 p/Share
30,000 Added 15.71%
160,909 Common Stock
Mar 22 2022
BUY
Open market or private purchase
$43,483 $1.98 p/Share
21,961 Added 14.37%
130,909 Common Stock
Mar 21 2022
BUY
Open market or private purchase
$23,214 $1.85 p/Share
12,548 Added 10.33%
108,948 Common Stock
Jan 07 2022
BUY
Grant, award, or other acquisition
-
48,200 Added 33.33%
96,400 Common Stock
Dec 14 2021
BUY
Grant, award, or other acquisition
-
48,200 Added 50.0%
48,200 Common Stock
Aug 10 2021
SELL
Exercise of conversion of derivative security
$12,777 $1.44 p/Share
8,873 Reduced 50.0%
8,873 Common Stock
Aug 10 2021
SELL
Open market or private sale
$13,080 $16.35 p/Share
800 Reduced 100.0%
0 Common Stock
Aug 10 2021
BUY
Open market or private sale
$131,127 $15.85 p/Share
8,273 Added 93.24%
600 Common Stock
Aug 09 2021
SELL
Open market or private sale
$262,800 $17.52 p/Share
15,000 Reduced 100.0%
0 Common Stock
Aug 09 2021
BUY
Exercise of conversion of derivative security
$21,600 $1.44 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jul 29 2021
SELL
Open market or private sale
$257,700 $17.18 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jul 29 2021
BUY
Exercise of conversion of derivative security
$21,600 $1.44 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jul 28 2021
SELL
Open market or private sale
$262,500 $17.5 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jul 28 2021
BUY
Exercise of conversion of derivative security
$21,600 $1.44 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jul 27 2021
SELL
Open market or private sale
$258,300 $17.22 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jul 27 2021
BUY
Exercise of conversion of derivative security
$21,600 $1.44 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jul 15 2021
SELL
Open market or private sale
$8,988 $19.54 p/Share
460 Reduced 100.0%
0 Common Stock
RP

Riccardo Perfetti

Chief Medical Officer
New York, NY

Track Institutional and Insider Activities on APLT

Follow Applied Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APLT shares.

Notify only if

Insider Trading

Get notified when an Applied Therapeutics Inc. insider buys or sells APLT shares.

Notify only if

News

Receive news related to Applied Therapeutics Inc.

Track Activities on APLT